Last reviewed · How we verify

NCT03390309

Evaluation of A Partially Hydrolyzed in Improving FGIDs Symptoms

Withdrawn NA Last updated 12 July 2018
What this trial tests

NA trial testing Partially Hydrolyzed Formula in Functional Gastrointestinal Disorders. Withdrawn.

Timeline
5 July 2018
Primary endpoint
30 December 2018
28 June 2019

Quick facts

Lead sponsorChildren's Hospital of Fudan University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Start date5 July 2018
Primary completion30 December 2018
Estimated completion28 June 2019

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Adults 1 Month to 6 Months, any sex, with Functional Gastrointestinal Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of A Partially Hydrolyzed Whey Protein Infant Formula in Improving Functional Gastrointestinal Disorders (FGIDs) Symptoms

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Functional Gastrointestinal Disorders

Currently open trials in the same condition.

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03390309.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing